PPT-Transfusion Medicine

Blood transfusion is like marriage it should not be entered upon lightly unadvisedly or wantonly or more often than is absolutely necessary Robert Beal past director of International Federation of Red Cross. Lyle R. Petersen, MD, MPH. Brad Biggerstaff, PhD. Division of Vector-Borne Diseases. Centers for Disease Control and Prevention. Blood Products Advisory Committee Meeting. December 14, 2010. Agenda. Arbovirus risk model. Orracha. . Kok. -. Kaew. , MD.. Anesthesiologist. Objectives. สามารถอธิบายถึงกลไกของร่างกายในการตอบสนองต่อการภาวะ . An Evidence-Based . Approach. Haneen . Yasin. Abdella, MD. Hematology Oncology . Kidz. Medical Services. Miami Children’s Hospital. Objectives. Review the definite indications for . leukoreduced. Which is the Culprit for Worse Outcomes in Cardiac Surgery?. Damien J. LaPar MD, MSc, James M. Isbell MD, MSCI, Jeffrey B. Rich MD, . Alan M. . Speir. MD, Mohammed . Quader. , MD, Irving L. . Kron. MD, . Elizabeth S. Allen, MD. Outline. Platelets. Problems with Platelets. Pathogen Reduced Platelets. UCSD Implementation Strategy. Objectives. Understand the risks of conventional platelet transfusion. Describe the mechanism and effects of pathogen reduction technology. Can you confidently abandon CMV seronegative products in the modern era of pre-storage leukoreduction?. Jeannie Callum, BA, MD, FRCPC. Really?. Are we still talking. about this in 2017?. Disclosure. Reduce Complications of . Prematurity. . A . Multi-site Quality Improvement Project. Sponsored . by the Indiana State Department of . Health. . Presenter: Sandra Hoesli, MD, MS. Objectives. Describe the Indiana Vermont Oxford Network Quality Collaborative (. Dr. Soheila . zareifar. Department of pediatric hematology/oncology. Shiraz university of medical sciences. Qeshm. 2018. Transfusion in Sickle Cell. In sickle cell disease transfusions improve blood flow by reducing the proportion of red cells capable of forming sickle hemoglobin polymer. . below is notmprehensive list it is representative of some common Blood FractionsexamplesInitial only those that you or the patientwill acceptProduct/Treatment Involving the Use of One146s Own Blood C . Daradka. University Of Jordan. School Of Medicine. General . S. urgery Department . A Transfusion Dilemma. A 72 year old woman presents to ER with a nosebleed. This is her second visit in 24 hours with the same complaint. Her nose is packed and the bleeding stops.. Medicine . Unit and Stem Cell Lab. Got Blood?. What’s Your Type?. Who Are We?. We . are 40 . NYS Licensed Medical Technologists and 4 Licensed Medical Physicians who specialize in Blood Banking, Transfusion Medicine, and Stem Cell Processing.. By – . Dr. Sunita Mittal. ▪. Blood transfusions  - basis of blood typing, Cross matching. ▪. Blood Storage in blood bank. ▪ Who can be a blood donor. . ▪. Complications of Blood transfusions (transfusion reactions). Massive transfusion protocol (MTPs) . Established to provide rapid blood replacement in a setting of severe . hemorrhage. Early optimal blood transfusion is essential to sustain organ perfusion and oxygenation. Released October 2014 Table of ContentsIntroductionDevelopment of a Massive Transfusion Protocol: Engagement and ScopeTriggers for Initiating Massive TransfusionBlood Product Resuscitation in the Trau